BAJAJ BROKING
Q4 Revenue: ₹465.85 crore, up 10.1% YoY from ₹423.74 crore
Q4 Net Profit: ₹20.31 crore, down 29.3% YoY from ₹28.74 crore
EBITDA: ₹42.60 crore, down 12.6% YoY
EBITDA Margin: 9% vs 11.4% YoY
PAT Margin: 4.36% vs 6.78% YoY
Morepen Labs Share Price: ₹60.36, up 7.10% intraday post-results
Despite a sharp drop in net profit and operating margins, Morepen Labs share price rose 7.10% intraday to close at ₹60.36. This positive movement indicates that investors may have reacted favourably to the 10.1% year-on-year revenue growth, suggesting steady demand across product lines.
However, the fall in EBITDA margin to 9% and PAT margin to 4.36% signals rising input costs and operational pressures. If this trend continues, it could impact future profitability. Investors are likely to monitor upcoming quarters for signs of recovery in margin performance and improved cost controls.
Source: The results mentioned above are based on the official stock exchange filing and board meeting outcome by Morepen Laboratories Ltd as of May 13, 2025.
Share this article:
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading